Cannabis Science Conference Spring with Dustin Sulak, DO

This month’s Healer webinar explored how recent cannabis policies impact patients, parents, and more.

GVB Biopharma announced their new CBT Isolate product.

Industry feedback is being considered in developing pathways to make CBD accessible – and safe – to treat minor health conditions without a prescription.

This survey assesses consumer awareness, usage patterns, and safety concerns with results indicating that cannabidiol (CBD), Δ8-tetrahydrocannabinol (Δ8-THC), and cannabinol (CBN) are the most frequently used cannabinoids, with vapes and edibles being the preferred methods of consumption.

Here, we bring you our top four recent news articles covering research for cannabis and ALS and autism, updates from the NCIA, and testing license applications in Alabama.

This webinar covered how cannabis for this neurodegenerative disease could provide better symptom relief and improve quality of life better than conventional treatments.